| Literature DB >> 11821904 |
Luzheng Liu1, Ann Chahroudi, Guido Silvestri, Mary E Wernett, William J Kaiser, Jeffrey T Safrit, Akira Komoriya, John D Altman, Beverly Z Packard, Mark B Feinberg.
Abstract
We have developed a non-radioactive flow-cytometry assay to monitor and quantify the target-cell killing activities mediated by cytotoxic T lymphocytes (CTLs). This flow-cytometry CTL (FCC) assay is predicated on measurement of CTL-induced caspase activation in target cells through detection of the specific cleavage of fluorogenic caspase substrates. Here we show that this assay reliably detects antigen-specific CTL killing of target cells, and demonstrate that it provides a more sensitive, more informative and safer alternative to the standard 51Cr-release assay most often used to quantify CTL responses. The FCC assay can be used to study CTL-mediated killing of primary host target cells of different cell lineages, and enables the study of antigen-specific cellular immune responses in real time at the single-cell level. As such, the FCC assay can provide a valuable tool for studies of infectious disease pathogenesis and development of new vaccines and immunotherapies.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11821904 DOI: 10.1038/nm0202-185
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440